drugset
drugset / Trial / NCT05575700

Safety of Ibuprofen After Major Orthopaedic Surgeries

NCT05575700 ↗

Phase 4 Completed 2904 enrolled Naestved Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Safety of an eight-day treatment with ibuprofen after primary hip and knee arthroplasties.

Timeline

Start
2023-04-17
Primary completion
2025-08-19
Completion
2025-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral

Indications

arthropathy